Johnson & Johnson MedTech announced today that the FDA granted its Ottava surgical robot investigational device exemption (IDE). The regulatory nod comes just under a month after the company ...

The Horizon Inspire System. [Image courtesy of Magstim] Magstim announced today that the FDA cleared its next-generation Horizon Inspire system for delivering transcranial magnetic stimulation (TMS).

The Varipulse catheter is a key component of the Varipulse pulse field ablation platform. [image courtesy of Biosense Webster/Johnson & Johnson MedTech] Johnson & Johnson MedTech announced today ...

The Genesis RMN system. [Image from Stereotaxis] Stereotaxis (NYSE:STXS) announced today that physicians at the University of Kansas Health System successfully treated the first patients with its ...

Percutaneous transmural arterial bypass (PTAB) using the Detour system. [Image courtesy of Endologix] Endologix announced the final 36-month results for the DETOUR2 study evaluating its Detour ...

Precision Neuroscience’s Layer 7 Cortical Interface [Photo courtesy of Precision Neuroscience] Precision Neuroscience recently closed a $93 million funding round, the brain–computer interface ...

Robert F. Kennedy Jr. and President-elect Donald Trump [Photo courtesy of Team Kennedy] Robert F. Kennedy Jr. — who claims President-elect Donald Trump promised him “control” of the U.S ...

Corin announced that it received FDA 510(k) clearance for its Icona femoral stem implant for total hip arthroplasty (THA). This clearance comes just one month after Corin won FDA clearance for its ...

Tandem Diabetes Care (Nasdaq:TNDM) shares ticked up after hours today on third-quarter results that topped the consensus forecast. Shares of TNDM rose 5% to $35.85 apiece in post-market trading today.

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform ...

The Lightning Flash 2.0 computer-assisted thrombectomy system. [Image courtesy of Penumbra] Penumbra (NYSE:PEN) today announced new data demonstrating improved outcomes with its computer-assisted ...

SimBioSys announced that it received its second FDA 510(k) clearance for TumorSight Viz to expand its use by breast surgeons in the U.S. Chicago-based SimBioSys picked up an initial FDA clearance ...